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Summary The preoperative concentrations of IgG were lower (P<0.002) and the concentrations of C4 and
C1-INH higher (P<0.01 and P<0.001) in 29 patients with recurrence after potentially curative resection of
gastric carcinoma, than in 31 patients alive and disease-free 5 years after surgery. These differences between
the two groups of patients were consistent within each of six groups of disease extent. In each of the two
groups of patients, the preoperative concentrations of IgG, C4 and Cl-INH had no significant variation with
the extent of disease (P>0.05 or greater). Of our variables, Cl-INH was the most potent prognosticator and
discriminated between patients with and without recurrence with 80% accuracy. Furthermore, the predictive
prognostic value of Cl-INH at the time of surgery was superior to the prognostic value of the extent of
disease (F values 27.00 and 12.69). Apparently, the preoperative Cl-INH concentration is an essential and
independent prognostic parameter of gastric carcinoma. We assume that Cl-INH reflects an additional
prognostic feature appropriate to the tumour or the host. Our finding that the interval between surgery and
death from recurrence had an inverse relation to the preoperative Cl-INH concentration also supports this
assumption.
We have previously described the preoperative serum concen-
trations of immunoglobulins (Ig) and some complement com-
ponents (C), and the erythrocyte sedimentation rate (ESR) in
relation to the extent of disease and prognosis in patients
with gastric carcinoma (Janssen et al., 1983, 1985, 1987a).
The levels of IgG decreased with advancing disease among
those resected for cure, whereas Cl-esterase inhibitor (Cl-
INH), C4 and ESR increased. Patients with recurrence had
lower preoperative concentrations of lgG and higher concen-
trations of Cl-INH than those alive and disease-free 21 years
after surgery.
The series of patients is now extended and the patients
have been followed for 5 years, which permits the retrieval of
further results. We have now searched for the exact predic-
tive value of our variables as to recurrence or no-recurrence.
The prognostic significance of the variables has also been
compared with the prognostic significance of the extent of
disease, which traditionally has been the prime indicator of
prognosis (Nielsen et al., 1985; Hartley et al., 1987; Craven,
1987; Sobin et al., 1988). Furthermore, we have also studied
whether our variables were independent prognostic
parameters or if they merely reflected the extent of disease at
the time of surgery.
Materials and methods
Patients
The preoperative serum concentrations of IgG, IgA, IgM,
C3, C4, Cl-INH and the levels of ESR were quantified in 99
patients who underwent curative intent resection of gastric
carcinoma in the Department of Surgery during the years
1977-82. Patients with other diseases or with a history of
another malignant disease within the last 5 years before gastric
cancer surgery were excluded. The mean age of the patients
(± ls.d.) was 66.1 ± 11.4 years and 40% were women.
After surgery the patients entered a regular follow-up pro-
gramme with examinations every 3 months in the first year
and later at 6-month intervals. The status of the series 5
years after surgery is shown in Table I.
During the first 5 years after surgery for gastric carcinoma,
eight patients had a second primary cancer. Colon cancer
appeared in three of them, urogential cancers in four and
squamous cell lung cancer in one.
Ten patients died from various causes without signs of
malignant disease at clincial or post mortem examination
(three patients). One patien-t died from complications after a
later laparotomy whereas nine patients died from cardiopul-
monary or cerebrovascular diseases.
Three patients were lost on follow-up. They are all dead; at
the last follow-up examination 1-3 months before death they
were without signs of malignancy.
Five years after surgery 31 patients were alive and without
clinical signs of disease. During follow-up 29 patients had a
clinical course consistent with recurrence of gastric car-
cinoma. These two groups of patients were compared.
The median time between surgery and clinical signs of
recurrence was 11.5 (range 2-59) months and the median
time between recurrence and death was 4.0 (range 0-34)
months.
The age difference between the patients with and without
recurrence was small (P>0.3), and there was no sex
difference between the groups (P>0.2). There was also no
difference in the surgical procedures for total gastrectomy vs
less extensive procedures (P>0.1) or splenectomy vs no
splenectomy (P>0. 1).
Pathology
Based on the post-surgical criteria advised by IUCC
(Harmer, 1978), the patients were divided into six groups of
disease extent at the time of surgery: TINOMO, T2NOMO,
T3NOMO, T2N + MO, T3N + MO and T4NXMO (Nx, i.e.
irrespective of lymph nodes). No patients with distant meta-
Table I Survey of 99 patients 5 years after potentially curative
surgery for gastric carcinoma (1977- 1982)
No. of
patients
Alive and clinically cancer-free 31
Clinical course consistent with recurrance 29
Cancer in the vicinity of the resection border 9
Died in hospital after the operation 9
Died later from various causes without evidence
of malignant disease 10
Second primary cancer after gastric cancer surgery 8
Lost on follow-up 3 Correspondence: C.W. Janssen Jr, Department of Surgery, Hauke-
land University Hospital, N-5021 Bergen, Norway.
Received 3 January 1989; and in revised form 31 March 1989.
Br. J. Cancer (1989), 60, 589-591 '." The Macmillan Press Ltd., 1989590 C.W. JANSSEN et al.
stases were resected for cure. There were no patients with
TIN + MO disease in the series.
Tumours were also grouped into histological types accord-
ing to Lauren's classification of intestinal type and diffuse
(Lauren, 1965).
Blood samples
Concentrations of IgG, IgA and IgM and the complement
components C3, C4 and C1-INH were quantified in sera as
previously described (Janssen et al., 1987a). ESR was
routinely recorded on admission to the hospital.
Statistics
Mean values were compared by Student's t test, preceded by
Fisher's test for comparison of variances. Distribution of
nominal data was tested by x2 test with Yates' modification.
ESR was transferred to the In-scale to fit better with a
normal distribution.
The predictive value of the variables was tested in a disc-
riminant analysis, performed by the program P7M in the
BMDP statistical software (Dixon, 1983). The groups of
disease extent were ranged in the order 1-6 and entered the
discriminant analysis as an independent variable.
Results
The patients with recurrence had lower preoperative concent-
rations of IgG and higher concentrations of C4 and C1-INH
than the disease-free patients (Table II). These differences
also held true within each group of disease extent. In each
group of patients with and without recurrence, the concentra-
tions of IgG, C4 and Cl-INH had no significant variation
with the extent of disease (P>0.05). ESR and the concentra-
tions of IgA, IgM and C3 were not different between the
patients with and without recurrence.
The disease extent was different between the patients with
and without recurrence, with an excess of recurrences among
the patients with lymph node metastases or T4 tumour,
0.005>P>0.001. The distribution of Lauren's histological
types of tumour was not different between the two groups of
patients (P>0.3).
The potential of the variables to discriminate between the
patients with and without recurrence was then tested. The
extent of disease grouped in the order 1-6 entered the disc-
riminant analysis. The most potent discriminator was Cl-
INH, with an F value more than twice as high as that of
disease extent (Table III). The prognostic potential of IgG
and C4 concentrations was slightly less than that of disease
extent. Furthermore, the disease extent, IgG and C4 gave
only insignificant additional information to that of Ci-INH
(F values were then respectively 3.46, 1.95, and 0.94).
With Cl-INH as the only variable, 80% of the patients
were classified correctly as to recurrence and non recurrence.
The calculated critical C1-INH concentration was 0.378 g 1'.
Among 29 patients with Cl-INHV 0.38 g 1', 24 (83%) were
in the recurrence group, whereas 24 patients out of 31 (77%)
Table III The potential (as F values) of disease extent (in groups
1-6) and the preoperative concentrations of IgG, C4 and C1-INH to
discriminate between patients with and without recurrence after
potentially curative surgery for gastric carcinoma
Variable F value Statistical
significance (df. = 1,58)
Disease extent 12.69 P<0.001
IgG 11.98 0.005>P>0.001
C4 7.10 0.O1>P>0.005
Cl-INH 27.00 P<0.001
Number ofpatients = 60.
with Cl-INH. 0.37g I' were alive and disease-free 5 years
after surgery.
The Cl-INH concentrations in the series ranged from 0.20
to 0.60 g [-'. The calculated chance for recurrence at various
levels of C1-INH is seen from Figure 1. With C1-INH at
either the lower or upper end of the range, the chances for
recurrence within 5 years after surgery were 2.6% and
98.9%, respectively.
The interval between surgery and death from recurrent
gastric carcinoma decreased with increasing C1-INH levels
preoperatively (Table IV). The median time between surgery
and death from recurrence was 9 months when the
preoperative C1-INH was >0.50 g 1-' as opposed to 24
months for the patient with C1-INH <0.30gl-'.
Thirteen patients died from other causes without signs of
malignant disease or were lost to follow-up. The mean con-
centrations of IgG, C4 and C1-INH in these patients were
compared to those of the patients with and without recur-
rence (Gamel et al., 1986). The values could not be assigned
to any of the two groups.
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Figure I The calculated chance for recurrence of gastric car-
cinoma within 5 years after potentially curative surgery at
different levels of preoperative Cl-INH serum concentrations.
Table 11 Preoperative ESR and serum concentrations (mean ± ls.d.) of
immunoglobulins and complement components in 29 patients with recurrence and in
31 patients alive and disease-free 5 years after potentially curative surgery for gastric
carcinoma.
Cancer No Significance of
recurrence recurrence differences
InESR(mm h-') 2.73±0.77 2.74±0.87 n.s.
IgG (g 1-') 8.50±2.37 11.43±3.94 0.002>P>0.001
IgA (g 1-') 2.29± 1.18 2.25± 1.19 n.s.
IgM (g 1'1) 1.22±0.60 1.23 0.58 n.s.
C3 (g 1') 0.92±0.27 0.86±0.16 n.s.
C4 (g I-') 0.46±0.13 0.37±0.11 0.01>P>0.005
CI-INH (g I ') 0.42±0.07 0.33±0.06 P<0.001SERUM Ci-ESTERASE INHIBITOR 591
Table IV The median interval (months) between potentially
curative surgery for gastric carcinoma and death from recurrence in
29 patients with various levels of preoperative Cl-INH
concentrations
CJ-INH conc. No. ofpatients Time
>0.20<0.30gI' 1 24
>0.30<0.40gI-' 11 18
>0.40<0.50gl ' 14 13
>0.50<0.60gl-' 3 9
Discussion
The preoperative serum concentrations of C1-INH, IgG and
C4 were different between 29 patients with recurrence after
potentially curative surgery for gastric carcinoma, and 31
patients who were alive and disease-free 5 years after surgery.
The differences between the groups were consistent within
each of six groups of disease extent. Furthermore, in each of
the two groups of patients the variables were insignificantly
associated with the disease extent. The between-group
differences of our variables can therefore not be explained by
the different stage distribution in the two groups.
When the prognostic significance of our variables was
compared to that of the disease extent, we clearly showed
that C1-INH was a more potent prognosticator than the
disease extent. Actually, the disease extent gave no further
prognostic information additional to Cl-INH. We therefore
assume that the preoperative serum concentration of C1-INH
in patients with gastric carcinoma reflects an additional prog-
nostic feature that is appropriate either to the tumour or the
host.
It has been claimed that serum C1-INH parallels disease
activity in cancer patients (Bach-Mortensen et al.,1975; Ast-
rup et al.,1977; Koller et al.,l979). Our finding that among
those with recurrence, the interval between surgery and death
from recurrence was shorter where the preoperative C1-INH
level was higher, also supports this opinion.
Serum IgG and C4 also gave insignificant prognostic in-
formation additional to C1-INH. This finding is in line with
a previous report, where we described correlations between
the concentrations of C1-INH and IgG, as well as Cl-INH
and C4 in gastric cancer patients (Janssen et al., 1983). The
preoperative ESR was nearly identical in the patients with
and without recurrence. Any prognostic significance of ESR
may have been confounded by the variations of ESR with
the different histological types of tumour (Janssen et al.,
1987b), which was not the case. What we suppose is that
ESR may reflect the tumour bearing state in one way or
another.
Carcinoembryonic antigen (CEA) is a much used prognos-
ticator of gastrointestinal malignancies. In patients with gast-
ric carcinoma the preoperative CEA is clearly stage related
(Janssen & 0rjasxeter, 1986; Shimizu et al., 1987; Koga et al.,
1987). The preoperative CEA concentrations were, however,
only slightly different (P <0.05) between patients with and
without recurrence after gastric cancer surgery (Janssen & 0rjaseter, 1986), which may be ascribed to the variations of
CEA with the histological types of tumour (Janssen et al.,
1987b).
We know of no other variable than the preoperative con-
centration of Cl-INH that can predict so significantly the
outcome after surgery for gastric carcinoma. This variable is
easily obtained in a routine immunological laboratory at low
cost and may be available before decisive therapy.
Two of us (Drs Janssen and Matre) dedicate this paper to our
teacher and friend Professor Olav T0nder on the occasion of his
retirement from his post as Professor of Immunology.
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